An Evaluation of the Safety, Tolerability and PK of Intravenous CT-P27

• Research type

  Research Study

• Full title

  A Phase I Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous CT-P27 in Healthy Subjects

• IRAS ID

  129006

• Contact name

  David James Alexander Bell

• Contact email

  david@biokineticeurope.com

• Sponsor organisation

  Celltrion

• Eudract number

  2013-000655-40

• ISRCTN Number

  to be applied for

• REC name

  Wales REC 1

• REC reference

  13/WA/0116

• Date of REC Opinion

  20 May 2013

• REC opinion

  Further Information Favourable Opinion